Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2000
11/09/2000WO2000028026A3 Gene expression modulated by opiate administration and withdrawal
11/09/2000WO2000027422A3 Methods and compositions for treating or preventing peripheral neuropathies
11/09/2000WO2000026367A3 Therapeutics and diagnostics for ocular abnormalities
11/09/2000WO2000026244A3 A novel tumor necrosis factor family member, drl, and related compositions and methods
11/09/2000WO2000024780A3 Compositions and methods for treating polycystic kidney disease
11/09/2000WO2000024771A3 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same
11/09/2000WO2000024768A3 Genes integrating signal transduction pathways
11/09/2000WO2000024765A3 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000WO2000024254A9 Compositions and methods for modulating expression within smooth muscle cells
11/09/2000WO2000023565A3 Novel neuropilin/growth factor binding and uses thereof
11/09/2000WO2000021996A3 Methods and compositions for inhibiting neoplastic cell growth
11/09/2000WO2000020638A3 Methods and compositions for the diagnosis and therapy of prostate cancer
11/09/2000WO2000020571A9 Maize promoters
11/09/2000WO2000018929A3 Paramyxovirus vaccines
11/09/2000WO2000015826A3 Leptin induced genes
11/09/2000WO2000015785A3 GENE MODIFICATION IN THE GENE FOR THE DIE Gβ3-SUB-UNIT OF HUMAN G-PROTEIN
11/09/2000WO2000014112A3 Papillomaviruses, means for the detection thereof and therapy for diseases caused thereby
11/09/2000WO2000009655A9 Genes amplified in cancer cells
11/09/2000WO2000006737A8 Streptococcus pneumoniae proteins and nucleic acid molecules
11/09/2000WO2000004050A3 Neurotrophic growth factor
11/09/2000WO1999058671A3 Human and nematode homologues of the yeast longevity assurance gene lag1
11/09/2000WO1999056769A3 Inhibition of helicobacter pylori proliferation
11/09/2000WO1999055868A3 Fizz proteins
11/09/2000WO1999047678A9 Interferon alpha plasmids and delivery systems, and methods of making and using the same
11/09/2000DE19921027A1 Verbindungen mit antibiotischer Wirkung Compounds with antibiotic activity
11/09/2000DE19920816A1 Cephaibole, neue Antiparasitika aus Acremonium tubakii, Verfahren zu ihrer Herstellung und Verwendung derselben Cephaibols new antiparasitic drugs from Acremonium tubakii, processes for their preparation and use thereof
11/09/2000DE19920712A1 Verfahren zum Herstellen eines rekombinanten Proteines A method for producing a recombinant Proteines
11/09/2000DE19919121A1 Multimeric cytomegalovirus antigen useful as an immunoassay reagent, and which comprises at least two p52 peptide sequences
11/09/2000CA2407714A1 Expression of heparin-binding protein in recombinant mammalian cells
11/09/2000CA2373045A1 Gene therapy using tgf-.beta.
11/09/2000CA2373021A1 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000CA2373018A1 Novel cellular regulation factor tto 20
11/09/2000CA2372946A1 Asialocytokines and treatment of liver disease
11/09/2000CA2372923A1 Dna encoding snorf36a and snorf36b receptors
11/09/2000CA2372834A1 Amplification of folate-mediated targeting to tumor cells using nanoparticles
11/09/2000CA2372803A1 Variants of traf2 which act as an inhibitor of tnf-alpha (tnf .alpha.) signaling pathway
11/09/2000CA2372559A1 Neurite outgrowth and guidance by tenascin-c
11/09/2000CA2372235A1 Conserved neisserial antigens
11/09/2000CA2372221A1 Methods for producing recombinant insulin from novel fusion proteins
11/09/2000CA2372214A1 Modified exendins and exendin agonists
11/09/2000CA2372192A1 Lim mineralization protein splice variants
11/09/2000CA2372190A1 Methods for the treatment of neuronal atrophy-associated dementia
11/09/2000CA2372187A1 Ras oncogen p21 peptide vaccines
11/09/2000CA2372022A1 Traf5 knockout mouse
11/09/2000CA2371702A1 Meg-3 protein
11/09/2000CA2371596A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof
11/09/2000CA2371442A1 Coleopteran-toxic polypeptide compositions and insect-resistant transgenic plants
11/09/2000CA2371032A1 Neisseria genomic sequences and methods of their use
11/09/2000CA2370821A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
11/09/2000CA2370587A1 Use of heparin-binding antagonists in the inhibition of bradykinin release
11/09/2000CA2370495A1 Peptides from the tt virus sequence and monospecific antibodies binding to the tt virus
11/09/2000CA2370252A1 Cancer treatment with endothelin receptor antagonists
11/09/2000CA2370177A1 Methods for the identification of compounds for the treatment of alzheimer's disease
11/09/2000CA2370134A1 Growth hormone-regulatable liver genes and proteins, and uses thereof
11/09/2000CA2370117A1 Method of detection of cytochrome b mutations in funghi leading to resistance against anti-fungal agents
11/09/2000CA2370113A1 Method of removing n-terminal alanine residues from polypeptides with aeromonas aminopeptidase
11/09/2000CA2370111A1 Optical probes and assays
11/09/2000CA2369964A1 Pesticidal fusions
11/09/2000CA2369747A1 Mutant human cd80 and compositions for and methods of making and using the same
11/09/2000CA2369371A1 Death domain containing receptor 5
11/09/2000CA2365440A1 Human ion channel proteins
11/09/2000CA2365278A1 Tumour-associated antigen
11/09/2000CA2336296A1 Novel peptide y-2
11/09/2000CA2335966A1 Method for inducing growth and enhancing survival of nervous tissue
11/08/2000EP1050585A2 PROMOTER AND REGULATOR SEQUENCES $i(Ha ds10 G1): A GENE LEA OF SUNFLOWER EXPRESSED EXCLUSIVELY IN SEEDS FROM THE MATURATION PHASE
11/08/2000EP1050582A2 Recombinant microorganisms expressing small rubber particle-associated protein
11/08/2000EP1050542A1 Novel potassium channel protein
11/08/2000EP1050541A1 Babesia vaccine
11/08/2000EP1050540A2 Inhibitors of dipeptidyl-aminopeptidase type IV
11/08/2000EP1049810A2 INHIBITION OF DNA MODULATION CAUSED BY MUTATED p53
11/08/2000EP1049800A1 Asthma related genes
11/08/2000EP1049799A1 Antimicrobial compounds
11/08/2000EP1049795A1 Mmsc1 - an mmac1 interacting protein
11/08/2000EP1049792A1 Methods for recovering polypeptides from plants and portions thereof
11/08/2000EP1049791A1 Methods and composition for modulating flavonoid content
11/08/2000EP1049788A2 Protein expression in baculovirus vector expression systems
11/08/2000EP1049783A2 Frozen food product
11/08/2000EP1049782A1 Mutants of il-16, processes for their production, and their use
11/08/2000EP1049781A1 Human chemokine and its use for detection and treatment of breast disease
11/08/2000EP1049780A1 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/08/2000EP1049779A2 Lh-receptor gene promoter for tissue-specific gene expression
11/08/2000EP1049778A2 Recombinant proteins derived from hgf and msp
11/08/2000EP1049777A1 Acpl dna and polypeptides
11/08/2000EP1049776A1 Phagocytosis genes and uses thereof
11/08/2000EP1049775A1 Human btrcp protein
11/08/2000EP1049771A2 Transgenic non-human mammal, a method for the production thereof, and the utilization thereof
11/08/2000EP1049770A1 Secreted proteins and polynucleotides encoding them
11/08/2000EP1049769A2 Mutant herpes simplex viruses and uses thereof
11/08/2000EP1049767A1 A transgenic rabbit that expresses a functional human lipoprotein (a)
11/08/2000EP1049716A1 Purification of fibrinogen
11/08/2000EP1049715A2 Rho family antagonists and their use to block inhibition of neurite outgrowth
11/08/2000EP1049714A1 Secreted proteins and polynucleotides encoding them
11/08/2000EP1049713A2 Antifreeze protein
11/08/2000EP1049712A2 Hybrid tetanus toxoid proteins that migrate retrogradely and transynaptically into the cns
11/08/2000EP1049711A1 Liposomes comprising peptide antigens derived from x protein of hepatitis b virus
11/08/2000EP1049710A1 Peptides with beta-1 integrin subunit dependent cell adhesion modulating activity
11/08/2000EP1049709A1 Novel peptides having biological activity
11/08/2000EP1049708A1 Meth1 and meth2 polynucleotides and polypeptides
11/08/2000EP1049490A2 Method for inhibiting cd95-independent apoptosis in aids
11/08/2000EP1049488A1 METHOD OF AND COMPOSITIONS FOR IMMUNIZATION WITH THE $i(PSEUDOMONAS) V ANTIGEN
1 ... 2096 2097 2098 2099 2100 2101 2102 2103 2104 2105 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 2116 ... 2916